The Clonal Hematopoiesis & Inflammation in Vasculature Registry and Biorepository

NCT06701214 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2024-11-22

No results posted yet for this study

Summary

This study will investigate the association between clonal hematopoiesis and other conditions. Clonal hematopoiesis (CH) refers to the mutations in a person's stem cells which commonly affect people as they get older. These mutations have notably been linked to increased risk of certain cancers as well as increased risk of heart disease.

Conditions

  • Clonal Hematopoiesis

Interventions

OTHER

Blood collection

Blood will be taken from participants already undergoing blood collection

OTHER

Saliva collection

Undergo saliva collection

OTHER

Bone marrow collection

Bone marrow will be taken from participants already undergoing bone marrow collection

Sponsors & Collaborators

  • Vanderbilt-Ingram Cancer Center

    lead OTHER

Principal Investigators

  • Alexander Bick, MD, PhD · Vanderbilt University/Ingram Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-28
Primary Completion
2030-11-30
Completion
2031-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06701214 on ClinicalTrials.gov